Chiron Capital Management LLC Has $30.61 Million Stake in Bristol-Myers Squibb (NYSE:BMY)

Chiron Capital Management LLC raised its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 0.3% in the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 478,673 shares of the biopharmaceutical company’s stock after purchasing an additional 1,538 shares during the period. Bristol-Myers Squibb accounts for about […]

Related Keywords

United States ,Philadelphia ,Pennsylvania ,Zurich ,Züsz ,Switzerland ,Blackrock ,America ,Pomalyst Imnovid ,Robertm Plenge ,Ann Powell ,Bristol Myers Squibb ,Blackrock Inc ,Bristol Myers Squibb Company ,Moneta Group Investment Advisors ,Bristol Myers Squibb Company Profile ,Credit Suisse Group ,Norges Bank ,Morgan Stanley ,Ameriprise Financial Inc ,Ltd Zurich ,Chiron Capital Management ,Securities Exchange Commission ,Bank Julius Baer Co ,Free Report ,Myers Squibb ,Capital Management ,Julius Baer ,Group Investment Advisors ,Exchange Commission ,Suisse Group ,Get Free Report ,Myers Squibb Company ,Visit Holdingschannel ,Bristol Myers Squibb Daily ,Nyse Bmy ,Bmy ,Medical ,11012210 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,